Kallinikova V D, Batmonkh Ts, Kosobokova E N, Pakhorukova L V, Ogloblina T A, Kravtsov E G, Karpenko L P, Matekin P V
Med Parazitol (Mosk). 2008 Jan-Mar(1):11-5.
Trypanosoma cruzi antibodies that are important in the anticancer effect of this species of Trypanosoma were first detected in 14% of the 374 examined intact mice. These background antibodies were polyclonal, i.e. they reacted with one or other of 9 genetically different T. cruzi clones and detected antigenic determinants in different structures of a Trypanosoma cell. Their spread in the population varied with animal batches; the titers were not greater than 1:40 and the level remained steady during a one-month observation. The growth of Ehrlich's adenomacarcinoma inoculated to these mice was inhibited by 1.5-2.5 times and, in some cases, terminated in total regression. The paper discusses the capacities of such antibodies in man and their inductor-commonness of the antigens of the normal intestinal microflora and the cells of the vertebrate with T. cruzi.
在374只接受检查的完整小鼠中,有14%首次检测到在这种克氏锥虫抗癌作用中起重要作用的克氏锥虫抗体。这些背景抗体是多克隆的,也就是说,它们与9个基因不同的克氏锥虫克隆中的一个或另一个发生反应,并在锥虫细胞的不同结构中检测到抗原决定簇。它们在群体中的传播因动物批次而异;滴度不超过1:40,并且在一个月的观察期内水平保持稳定。接种到这些小鼠体内的艾氏腺癌的生长受到1.5至2.5倍的抑制,在某些情况下,最终完全消退。本文讨论了此类抗体在人体内的能力以及它们的诱导物——正常肠道微生物群抗原与脊椎动物细胞和克氏锥虫的共同性。